Alveolar Soft Part Sarcoma: Clinical Trials

4 trials for Alveolar Soft Part Sarcoma, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

3 recruiting, 1 withdrawn. 4 Phase 1, 1 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 14Recruiting 3, Withdrawn 1
Phase 21Recruiting 1

Follow Alveolar Soft Part Sarcoma: new trials by email Literature Review of Alveolar Soft Part Sarcoma trials Research Report on Alveolar Soft Part Sarcoma

Trials (filtered) newest first · largest first

All 4 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
GCAR1, a Chimeric Antigen Receptor (CAR) T-CELL Therapy for Relapsed/Refractory GPNMB-Expressing Solid Tumours
Fludarabine, Cyclophosphamide, GCAR1 - Alveolar Soft Part Sarcoma, Renal Cell Carcinoma
Phase 1RecruitingCanadian Cancer Trials Group302026-08-302026-11-12
Alpha/Beta T and B Cell Depletion With Zoledronic Acid for Solid Tumors
Miltenyi CliniMACS Prodigy ® system, Zoledronic acid - Neuroblastoma, Rhabdomyosarcoma
Phase 1 / Phase 2RecruitingUniversity of Florida272026-02-112026-06-30
AB122 Platform Study
AB122, TAS-116, TAS-120 - Advanced or Metastatic Solid Tumor, Pancreatic Ductal Adenocarcinoma
Phase 1RecruitingTaiho Pharmaceutical Co., Ltd.9172021-06-012026-08-05
Selinexor in Combination With Ixazomib for the Treatment of Advanced Sarcoma
Selinexor, Ixazomib - Liposarcoma, Malignant Peripheral Nerve Sheath Tumors
Phase 1WithdrawnMatthew Ingham2020-11-012020-11-27

Narrower conditions

Sarcoma, Alveolar Soft Part (4)  ·  Sarcoma (2)  ·  Sarcoma, Ewing (2)  ·  Biliary Tract Neoplasms (1)  ·  Carcinoma, Non-Small-Cell Lung (1)  ·  Carcinoma, Renal Cell (1)  ·  Chordoma (1)  ·  Colorectal Neoplasms (1)  ·  Desmoplastic Small Round Cell Tumor (1)  ·  Esophageal Neoplasms (1)  ·  Head and Neck Neoplasms (1)  ·  Liposarcoma (1)  ·  Myoepithelioma (1)  ·  Neoplasm Metastasis (1)  ·  Nerve Sheath Neoplasms (1)

Broader conditions

Neoplasms (4)  ·  Neoplasms by Histologic Type (4)  ·  Neoplasms, Connective and Soft Tissue (4)  ·  Neoplasms, Muscle Tissue (4)  ·  Neoplasms by Site (3)  ·  Female Urogenital Diseases (2)  ·  Female Urogenital Diseases and Pregnancy Complications (2)  ·  Kidney Diseases (2)  ·  Kidney Neoplasms (2)  ·  Male Urogenital Diseases (2)  ·  Neoplasms, Bone Tissue (2)  ·  Neoplasms, Connective Tissue (2)  ·  Neoplasms, Glandular and Epithelial (2)  ·  Neoplasms, Nerve Tissue (2)  ·  Nervous System Diseases (2)

Interventions

130-nm albumin-bound paclitaxel (1)  ·  4-(2-fluoro-4-((((2-phenylacetyl)amino)thioxomethyl)amino)phenoxy)-7-methoxy-N-methyl-6-quinolinecarboxamide (1)  ·  Bevacizumab (1)  ·  Carboplatin (1)  ·  Cisplatin (1)  ·  Cyclophosphamide (1)  ·  Fluorouracil (1)  ·  Gemcitabine (1)  ·  Ramucirumab (1)  ·  TAS-116 (1)  ·  Zoledronic Acid (1)  ·  fludarabine (1)  ·  futibatinib (1)  ·  ixazomib (1)  ·  selinexor (1)

Sponsors

Canadian Cancer Trials Group (1)  ·  Matthew Ingham (1)  ·  Taiho Pharmaceutical Co., Ltd. (1)  ·  University of Florida (1)

Countries

United States (2)  ·  Canada (1)  ·  Japan (1)

Top investigators

Jordan Milner, MD (1)  ·  Matthew Ingham, MD (1)  ·  Mona Shafey (1)